Edition:
India

Cumberland Pharmaceuticals Inc (CPIX.OQ)

CPIX.OQ on NASDAQ Stock Exchange Global Select Market

6.74USD
23 Feb 2018
Change (% chg)

$-0.11 (-1.61%)
Prev Close
$6.85
Open
$6.70
Day's High
$6.90
Day's Low
$6.70
Volume
2,342
Avg. Vol
3,892
52-wk High
$7.95
52-wk Low
$5.30

Chart for

About

Cumberland Pharmaceuticals Inc. (Cumberland) is a specialty pharmaceutical company. The Company is focused on the acquisition, development and commercialization of branded prescription products. The Company operates through specialty pharmaceutical products segment. The Company's product portfolio includes Acetadote (acetylcyste... (more)

Overall

Beta: 0.91
Market Cap(Mil.): $112.71
Shares Outstanding(Mil.): 15.90
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.60
EPS (TTM): -- -- --
ROI: -- 14.91 10.66
ROE: -- 16.41 14.30

BRIEF-Cumberland Pharma Says Data Demonstrates Amifostine Reduces Gastro-Intestinal Toxicity For Multiple Myeloma Patients

* CUMBERLAND PHARMACEUTICALS INC - NEWLY PUBLISHED DATA DEMONSTRATES AMIFOSTINE REDUCES GASTRO-INTESTINAL TOXICITY FOR MULTIPLE MYELOMA PATIENTS Source text for Eikon: Further company coverage:

30 Jan 2018

BRIEF-Cumberland Pharmaceuticals Inc files for mixed shelf of up to $100 million

* Cumberland Pharmaceuticals Inc files for mixed shelf of up to $100 million Source text: (http://bit.ly/2jazuqV) Further company coverage:

08 Nov 2017

BRIEF-Cumberland Pharmaceutical reports Q3 loss per share $0.05

* Cumberland Pharmaceutical reports 27% revenue growth in the third quarter

08 Nov 2017

BRIEF-Cumberland Pharmaceuticals launches promotion of Totect in U.S. for emergency oncology intervention

* Cumberland Pharmaceuticals launches promotion of Totect® in the U.S. for emergency oncology intervention

25 Sep 2017

Earnings vs. Estimates